Published Online: Friday, September 1, 2006

The American Society of Consultant Pharmacists (ASCP) recently addressed medication therapy management services (MTMS) in long-term care. MTMS programs are expected to (1) optimize therapeutic outcomes through improved medication use; (2) reduce the risk of adverse events, including adverse drug interactions; (3) be conducted by a pharmacist or other qualified health care provider; and (4) differentiate between services in ambulatory and institutional settings.

In its policy statement, ASCP highlighted the following points:

  • ASCP advocates that Part D sponsors provide flexibility in the MTMS offered to patients of long-term care facilities and that these services mirror the unique differences in these residents and settings
  • The MTMS program should mainly focus on optimizing therapeutic outcomes and reducing adverse drug events for the beneficiary, and secondarily focus on reductions of drug costs when necessary
  • Pharmacists who provide MTMS to long-term care facility residents should have expertise in geriatric drug therapy
  • MTMS recommendations received by the administrator, prescriber, pharmacy provider, or caregiver/resident are best reconciled by the facility's consultant pharmacist

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues